About LDN Aware

The mission of this website is to spread public awareness of LDN worldwide.

The more people who know about LDN the more people will benefit from LDN.

The LDN Aware Project Team:

• Mary Bradley
• Jane Cundall
• Linda Elsegood
• Cris Kerr
• Lee Reynolds
• Graham Robson-Parker
• Julia Schopick 
• Jayne Thomas
• Malcolm West

What is LDN?  Low dose naltrexone, where naltrexone is used in doses approximately one-tenth those used for drug/alcohol rehabilitation purposes, is being used as an "off-label" treatment for certain immunologically-related disorders. The use of LDN for such diseases as cancer was first proposed by Ian Zagon, PhD, and LDN's broader clinical effects in humans were proposed by Bernard Bihari, MD.      

Link Policy: LDN Aware will list any website, anywhere in the world, as long as the website covers a health condition (see "Conditions" page) where LDN could be of benefit.  In return, we request that the LDN Aware logo and link be added to that website.  Other websites are welcome to add the LDN Aware logo and link upon prior approval of LDN Aware.